Clinical Trial Update: A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer [Phase 1]

View source ↗

Summary

NBF-006's Phase 1 trial in non-small cell lung cancer, pancreatic cancer, and colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• NBF-006

Snippet

Sponsor: Nitto BioPharma, Inc. | Conditions: Non-Small Cell Lung Cancer, Pancreatic Cancer | Phase 1 | Status: COMPLETED